Search For "selution slr"
MedAlliance announces completion of enrollment in Japanese SELUTION SLR
Updated : 4 years, 6 months ago IST
Geneva [Switzerland], September 23 (ANI/PRNewswire): MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR™, for the treatment of peripheral arterial disease (PAD).
Read More
MedAlliance announces first patient enrolled in the 3,300 Patient Landmark
Updated : 4 years, 6 months ago IST
Geneva [Switzerland], September 1 (ANI/PRNewswire): MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR™, a novel sirolimus drug-eluting balloon [DEB], ver
Read More
MedAlliance announces completion of enrolment in PRISTINE clinical trial w
Updated : 4 years, 7 months ago IST
Nyon [Switzerland], August 13 (ANI/PRNewswire): MedAlliance has announced completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of patients with Below-the-Knee (BTK) disease.
Read More
First patient enrolled in SELUTION SLR™ SUCCESS PTA study
Updated : 5 years, 1 month ago IST
Nyon [Switzerland], February 11 (ANI/PRNewswire): MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon SELUTION SLR™ for the treatment of patients with peripheral artery disease (PAD).
Read More
MedAlliance gains CE Mark approval for coronary SELUTION SLR™ Siroli
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India] June 16 (ANI/PRNewswire): MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease.
Read More